Rasagiline formulations of improved content uniformity

Details for Australian Patent Application No. 2006216696 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Peskin, Tirtza Berger

Agent FB Rice

Pub. Number AU-B-2006216696

PCT Pub. Number WO2006/091657

Priority 60/720,908 27.09.05 US; 60/655,622 23.02.05 US

Filing date 22 February 2006

Wipo publication date 31 August 2006

Acceptance publication date 18 August 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

6 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091657 Priority application(s): WO2006/091657

18 August 2011 Application Accepted

  Published as AU-B-2006216696

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216697-Apparatus and catalytic partial oxidation process for recovering sulfur from an H2S-containing gas stream

2006216695-Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof